AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
-2.48%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$10.7B
AUM Growth
+$5.97B
(+126%)
Cap. Flow
+$6.2B
Cap. Flow
% of AUM
57.93%
Top 10 Holdings %
Top 10 Hldgs %
89.3%
Holding
662
New
163
Increased
138
Reduced
149
Closed
136
Top Buys
| 1 |
Financial Select Sector SPDR Fund
XLF
|
+$2.46B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.32B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.19B |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$699M |
| 5 |
Fortinet
FTNT
|
+$684M |
Top Sells
| 1 |
TSMC
TSM
|
+$1.11B |
| 2 |
Wells Fargo
WFC
|
+$237M |
| 3 |
Bank of America
BAC
|
+$222M |
| 4 |
JPMorgan Chase
JPM
|
+$204M |
| 5 |
Global X Copper Miners ETF NEW
COPX
|
+$159M |
Sector Composition
| 1 | Technology | 16.61% |
| 2 | Financials | 4.63% |
| 3 | Industrials | 2.96% |
| 4 | Consumer Discretionary | 1.21% |
| 5 | Consumer Staples | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Harmony Biosciences
HRMY
$1.96B
| $43K | ﹤0.01% |
885
-317
| -26% | -$15.4K |
|
377
Qiagen
QGEN
$10.2B
| $43K | ﹤0.01% |
824
-18
| -2% | -$939 |
|
378
Cardinal Health
CAH
$36B
| $42K | ﹤0.01% |
+730
| New | +$42K |
|
379
Envista
NVST
$3.46B
| $42K | ﹤0.01% |
+870
| New | +$42K |
|
380
Tandem Diabetes Care
TNDM
$849M
| $42K | ﹤0.01% |
365
-473
| -56% | -$54.4K |
|
381
Verisk Analytics
VRSK
$37.5B
| $42K | ﹤0.01% |
195
-25
| -11% | -$5.39K |
|
382
West Pharmaceutical
WST
$18.1B
| $42K | ﹤0.01% |
103
-185
| -64% | -$75.4K |
|
383
Zurn Elkay Water Solutions
ZWS
$7.69B
| $42K | ﹤0.01% |
1,197
+54
| +5% | +$1.9K |
|
384
Acuity Brands
AYI
$10.1B
| $41K | ﹤0.01% |
219
+9
| +4% | +$1.69K |
|
385
Catalyst Pharmaceutical
CPRX
$2.45B
| $41K | ﹤0.01% |
4,965
-1,797
| -27% | -$14.8K |
|
386
Fastenal
FAST
$55B
| $41K | ﹤0.01% |
1,394
-172
| -11% | -$5.06K |
|
387
Mueller Industries
MLI
$10.6B
| $41K | ﹤0.01% |
1,518
+68
| +5% | +$1.84K |
|
388
Neurocrine Biosciences
NBIX
$14.3B
| $41K | ﹤0.01% |
+435
| New | +$41K |
|
389
Pacira BioSciences
PCRX
$1.18B
| $41K | ﹤0.01% |
+538
| New | +$41K |
|
390
Supernus Pharmaceuticals
SUPN
$2.58B
| $41K | ﹤0.01% |
+1,273
| New | +$41K |
|
391
Visa
V
$668B
| $41K | ﹤0.01% |
+185
| New | +$41K |
|
|
MDRX
392
DELISTED
Veradigm Inc. Common Stock
MDRX
| $41K | ﹤0.01% |
+1,837
| New | +$41K |
|
|
TVTY
393
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $41K | ﹤0.01% |
+1,276
| New | +$41K |
|
394
A10 Networks
ATEN
$1.26B
| $40K | ﹤0.01% |
2,838
+127
| +5% | +$1.79K |
|
395
BioMarin Pharmaceuticals
BMRN
$10.7B
| $40K | ﹤0.01% |
+515
| New | +$40K |
|
396
Boston Scientific
BSX
$160B
| $40K | ﹤0.01% |
+900
| New | +$40K |
|
397
Chemed
CHE
$6.74B
| $40K | ﹤0.01% |
79
-18
| -19% | -$9.11K |
|
398
Cooper Companies
COO
$13.6B
| $40K | ﹤0.01% |
+380
| New | +$40K |
|
399
Dover
DOV
$24B
| $40K | ﹤0.01% |
256
-31
| -11% | -$4.84K |
|
400
Comfort Systems
FIX
$25B
| $40K | ﹤0.01% |
454
+21
| +5% | +$1.85K |
|